Request for Covid-19 Impact Assessment of this Report
The United States Sterile Active Pharmaceutical Ingredients market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sterile Active Pharmaceutical Ingredients market, reaching US$ million by the year 2028. As for the Europe Sterile Active Pharmaceutical Ingredients landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sterile Active Pharmaceutical Ingredients players cover Aurobindo Pharma, Teva Pharmaceutical Industries, Corden Pharma, and Dalton Pharma Services, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Active Pharmaceutical Ingredients market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Aqueous
Non-aqueous Liquid
Dry Powder
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aurobindo Pharma
Teva Pharmaceutical Industries
Corden Pharma
Dalton Pharma Services
Pfizer
Sun Pharmaceutical Industries
Lonza Group
Albany Molecular Research
Sanofi
Dr. Reddy’s Laboratories
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sterile Active Pharmaceutical Ingredients Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sterile Active Pharmaceutical Ingredients by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sterile Active Pharmaceutical Ingredients by Country/Region, 2017, 2022 & 2028
2.2 Sterile Active Pharmaceutical Ingredients Segment by Type
2.2.1 Aqueous
2.2.2 Non-aqueous Liquid
2.2.3 Dry Powder
2.2.4 Others
2.3 Sterile Active Pharmaceutical Ingredients Sales by Type
2.3.1 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
2.3.2 Global Sterile Active Pharmaceutical Ingredients Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Type (2017-2022)
2.4 Sterile Active Pharmaceutical Ingredients Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Sterile Active Pharmaceutical Ingredients Sales by Application
2.5.1 Global Sterile Active Pharmaceutical Ingredients Sale Market Share by Application (2017-2022)
2.5.2 Global Sterile Active Pharmaceutical Ingredients Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Application (2017-2022)
3 Global Sterile Active Pharmaceutical Ingredients by Company
3.1 Global Sterile Active Pharmaceutical Ingredients Breakdown Data by Company
3.1.1 Global Sterile Active Pharmaceutical Ingredients Annual Sales by Company (2020-2022)
3.1.2 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Company (2020-2022)
3.2 Global Sterile Active Pharmaceutical Ingredients Annual Revenue by Company (2020-2022)
3.2.1 Global Sterile Active Pharmaceutical Ingredients Revenue by Company (2020-2022)
3.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company (2020-2022)
3.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Company
3.4 Key Manufacturers Sterile Active Pharmaceutical Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sterile Active Pharmaceutical Ingredients Product Location Distribution
3.4.2 Players Sterile Active Pharmaceutical Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sterile Active Pharmaceutical Ingredients by Geographic Region
4.1 World Historic Sterile Active Pharmaceutical Ingredients Market Size by Geographic Region (2017-2022)
4.1.1 Global Sterile Active Pharmaceutical Ingredients Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sterile Active Pharmaceutical Ingredients Annual Revenue by Geographic Region
4.2 World Historic Sterile Active Pharmaceutical Ingredients Market Size by Country/Region (2017-2022)
4.2.1 Global Sterile Active Pharmaceutical Ingredients Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sterile Active Pharmaceutical Ingredients Annual Revenue by Country/Region
4.3 Americas Sterile Active Pharmaceutical Ingredients Sales Growth
4.4 APAC Sterile Active Pharmaceutical Ingredients Sales Growth
4.5 Europe Sterile Active Pharmaceutical Ingredients Sales Growth
4.6 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Growth
5 Americas
5.1 Americas Sterile Active Pharmaceutical Ingredients Sales by Country
5.1.1 Americas Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022)
5.1.2 Americas Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022)
5.2 Americas Sterile Active Pharmaceutical Ingredients Sales by Type
5.3 Americas Sterile Active Pharmaceutical Ingredients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sterile Active Pharmaceutical Ingredients Sales by Region
6.1.1 APAC Sterile Active Pharmaceutical Ingredients Sales by Region (2017-2022)
6.1.2 APAC Sterile Active Pharmaceutical Ingredients Revenue by Region (2017-2022)
6.2 APAC Sterile Active Pharmaceutical Ingredients Sales by Type
6.3 APAC Sterile Active Pharmaceutical Ingredients Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sterile Active Pharmaceutical Ingredients by Country
7.1.1 Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022)
7.1.2 Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022)
7.2 Europe Sterile Active Pharmaceutical Ingredients Sales by Type
7.3 Europe Sterile Active Pharmaceutical Ingredients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients by Country
8.1.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022)
8.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type
8.3 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sterile Active Pharmaceutical Ingredients
10.3 Manufacturing Process Analysis of Sterile Active Pharmaceutical Ingredients
10.4 Industry Chain Structure of Sterile Active Pharmaceutical Ingredients
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sterile Active Pharmaceutical Ingredients Distributors
11.3 Sterile Active Pharmaceutical Ingredients Customer
12 World Forecast Review for Sterile Active Pharmaceutical Ingredients by Geographic Region
12.1 Global Sterile Active Pharmaceutical Ingredients Market Size Forecast by Region
12.1.1 Global Sterile Active Pharmaceutical Ingredients Forecast by Region (2023-2028)
12.1.2 Global Sterile Active Pharmaceutical Ingredients Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sterile Active Pharmaceutical Ingredients Forecast by Type
12.7 Global Sterile Active Pharmaceutical Ingredients Forecast by Application
13 Key Players Analysis
13.1 Aurobindo Pharma
13.1.1 Aurobindo Pharma Company Information
13.1.2 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product Offered
13.1.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aurobindo Pharma Main Business Overview
13.1.5 Aurobindo Pharma Latest Developments
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Information
13.2.2 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
13.2.3 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Pharmaceutical Industries Main Business Overview
13.2.5 Teva Pharmaceutical Industries Latest Developments
13.3 Corden Pharma
13.3.1 Corden Pharma Company Information
13.3.2 Corden Pharma Sterile Active Pharmaceutical Ingredients Product Offered
13.3.3 Corden Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Corden Pharma Main Business Overview
13.3.5 Corden Pharma Latest Developments
13.4 Dalton Pharma Services
13.4.1 Dalton Pharma Services Company Information
13.4.2 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product Offered
13.4.3 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dalton Pharma Services Main Business Overview
13.4.5 Dalton Pharma Services Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Sterile Active Pharmaceutical Ingredients Product Offered
13.5.3 Pfizer Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sun Pharmaceutical Industries
13.6.1 Sun Pharmaceutical Industries Company Information
13.6.2 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
13.6.3 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sun Pharmaceutical Industries Main Business Overview
13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 Lonza Group
13.7.1 Lonza Group Company Information
13.7.2 Lonza Group Sterile Active Pharmaceutical Ingredients Product Offered
13.7.3 Lonza Group Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lonza Group Main Business Overview
13.7.5 Lonza Group Latest Developments
13.8 Albany Molecular Research
13.8.1 Albany Molecular Research Company Information
13.8.2 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product Offered
13.8.3 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Albany Molecular Research Main Business Overview
13.8.5 Albany Molecular Research Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Sterile Active Pharmaceutical Ingredients Product Offered
13.9.3 Sanofi Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Dr. Reddy’s Laboratories
13.10.1 Dr. Reddy’s Laboratories Company Information
13.10.2 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product Offered
13.10.3 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Dr. Reddy’s Laboratories Main Business Overview
13.10.5 Dr. Reddy’s Laboratories Latest Developments
14 Research Findings and Conclusion
Table 1. Sterile Active Pharmaceutical Ingredients Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sterile Active Pharmaceutical Ingredients Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aqueous
Table 4. Major Players of Non-aqueous Liquid
Table 5. Major Players of Dry Powder
Table 6. Major Players of Others
Table 7. Global Sterile Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (Kiloton)
Table 8. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
Table 9. Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & ($ million)
Table 10. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2022)
Table 11. Global Sterile Active Pharmaceutical Ingredients Sale Price by Type (2017-2022) & (US$/Ton)
Table 12. Global Sterile Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (Kiloton)
Table 13. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Table 14. Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2017-2022)
Table 15. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2022)
Table 16. Global Sterile Active Pharmaceutical Ingredients Sale Price by Application (2017-2022) & (US$/Ton)
Table 17. Global Sterile Active Pharmaceutical Ingredients Sales by Company (2020-2022) & (Kiloton)
Table 18. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Company (2020-2022)
Table 19. Global Sterile Active Pharmaceutical Ingredients Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company (2020-2022)
Table 21. Global Sterile Active Pharmaceutical Ingredients Sale Price by Company (2020-2022) & (US$/Ton)
Table 22. Key Manufacturers Sterile Active Pharmaceutical Ingredients Producing Area Distribution and Sales Area
Table 23. Players Sterile Active Pharmaceutical Ingredients Products Offered
Table 24. Sterile Active Pharmaceutical Ingredients Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sterile Active Pharmaceutical Ingredients Sales by Geographic Region (2017-2022) & (Kiloton)
Table 28. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sterile Active Pharmaceutical Ingredients Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sterile Active Pharmaceutical Ingredients Sales by Country/Region (2017-2022) & (Kiloton)
Table 32. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sterile Active Pharmaceutical Ingredients Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (Kiloton)
Table 36. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)
Table 37. Americas Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)
Table 39. Americas Sterile Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (Kiloton)
Table 40. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
Table 41. Americas Sterile Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (Kiloton)
Table 42. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Table 43. APAC Sterile Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (Kiloton)
Table 44. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)
Table 45. APAC Sterile Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2017-2022)
Table 47. APAC Sterile Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (Kiloton)
Table 48. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
Table 49. APAC Sterile Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (Kiloton)
Table 50. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Table 51. Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (Kiloton)
Table 52. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)
Table 53. Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)
Table 55. Europe Sterile Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (Kiloton)
Table 56. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
Table 57. Europe Sterile Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (Kiloton)
Table 58. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (Kiloton)
Table 60. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (Kiloton)
Table 64. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (Kiloton)
Table 66. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sterile Active Pharmaceutical Ingredients
Table 68. Key Market Challenges & Risks of Sterile Active Pharmaceutical Ingredients
Table 69. Key Industry Trends of Sterile Active Pharmaceutical Ingredients
Table 70. Sterile Active Pharmaceutical Ingredients Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sterile Active Pharmaceutical Ingredients Distributors List
Table 73. Sterile Active Pharmaceutical Ingredients Customer List
Table 74. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Region (2023-2028) & (Kiloton)
Table 75. Global Sterile Active Pharmaceutical Ingredients Sales Market Forecast by Region
Table 76. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sterile Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (Kiloton)
Table 79. Americas Sterile Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sterile Active Pharmaceutical Ingredients Sales Forecast by Region (2023-2028) & (Kiloton)
Table 81. APAC Sterile Active Pharmaceutical Ingredients Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sterile Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (Kiloton)
Table 83. Europe Sterile Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (Kiloton)
Table 85. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Type (2023-2028) & (Kiloton)
Table 87. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Application (2023-2028) & (Kiloton)
Table 91. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2023-2028)
Table 94. Aurobindo Pharma Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 95. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product Offered
Table 96. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 97. Aurobindo Pharma Main Business
Table 98. Aurobindo Pharma Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
Table 101. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Corden Pharma Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 105. Corden Pharma Sterile Active Pharmaceutical Ingredients Product Offered
Table 106. Corden Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 107. Corden Pharma Main Business
Table 108. Corden Pharma Latest Developments
Table 109. Dalton Pharma Services Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 110. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product Offered
Table 111. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 112. Dalton Pharma Services Main Business
Table 113. Dalton Pharma Services Latest Developments
Table 114. Pfizer Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 115. Pfizer Sterile Active Pharmaceutical Ingredients Product Offered
Table 116. Pfizer Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 117. Pfizer Main Business
Table 118. Pfizer Latest Developments
Table 119. Sun Pharmaceutical Industries Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 120. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
Table 121. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 122. Sun Pharmaceutical Industries Main Business
Table 123. Sun Pharmaceutical Industries Latest Developments
Table 124. Lonza Group Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 125. Lonza Group Sterile Active Pharmaceutical Ingredients Product Offered
Table 126. Lonza Group Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 127. Lonza Group Main Business
Table 128. Lonza Group Latest Developments
Table 129. Albany Molecular Research Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 130. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product Offered
Table 131. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 132. Albany Molecular Research Main Business
Table 133. Albany Molecular Research Latest Developments
Table 134. Sanofi Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 135. Sanofi Sterile Active Pharmaceutical Ingredients Product Offered
Table 136. Sanofi Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 137. Sanofi Main Business
Table 138. Sanofi Latest Developments
Table 139. Dr. Reddy’s Laboratories Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 140. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product Offered
Table 141. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 142. Dr. Reddy’s Laboratories Main Business
Table 143. Dr. Reddy’s Laboratories Latest Developments
List of Figures
Figure 1. Picture of Sterile Active Pharmaceutical Ingredients
Figure 2. Sterile Active Pharmaceutical Ingredients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2017-2028 (Kiloton)
Figure 7. Global Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sterile Active Pharmaceutical Ingredients Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aqueous
Figure 10. Product Picture of Non-aqueous Liquid
Figure 11. Product Picture of Dry Powder
Figure 12. Product Picture of Others
Figure 13. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2021
Figure 14. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2022)
Figure 15. Sterile Active Pharmaceutical Ingredients Consumed in CNS
Figure 16. Global Sterile Active Pharmaceutical Ingredients Market: CNS (2017-2022) & (Kiloton)
Figure 17. Sterile Active Pharmaceutical Ingredients Consumed in Cardiovascular
Figure 18. Global Sterile Active Pharmaceutical Ingredients Market: Cardiovascular (2017-2022) & (Kiloton)
Figure 19. Sterile Active Pharmaceutical Ingredients Consumed in Genitourinary/Hormonal Drugs
Figure 20. Global Sterile Active Pharmaceutical Ingredients Market: Genitourinary/Hormonal Drugs (2017-2022) & (Kiloton)
Figure 21. Sterile Active Pharmaceutical Ingredients Consumed in Respiratory
Figure 22. Global Sterile Active Pharmaceutical Ingredients Market: Respiratory (2017-2022) & (Kiloton)
Figure 23. Sterile Active Pharmaceutical Ingredients Consumed in Rheumatology
Figure 24. Global Sterile Active Pharmaceutical Ingredients Market: Rheumatology (2017-2022) & (Kiloton)
Figure 25. Sterile Active Pharmaceutical Ingredients Consumed in Diabetes
Figure 26. Global Sterile Active Pharmaceutical Ingredients Market: Diabetes (2017-2022) & (Kiloton)
Figure 27. Sterile Active Pharmaceutical Ingredients Consumed in Oncology
Figure 28. Global Sterile Active Pharmaceutical Ingredients Market: Oncology (2017-2022) & (Kiloton)
Figure 29. Sterile Active Pharmaceutical Ingredients Consumed in Others
Figure 30. Global Sterile Active Pharmaceutical Ingredients Market: Others (2017-2022) & (Kiloton)
Figure 31. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)
Figure 32. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application in 2021
Figure 33. Sterile Active Pharmaceutical Ingredients Revenue Market by Company in 2021 ($ Million)
Figure 34. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company in 2021
Figure 35. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Geographic Region (2017-2022)
Figure 36. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Geographic Region in 2021
Figure 37. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)
Figure 38. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country/Region in 2021
Figure 39. Americas Sterile Active Pharmaceutical Ingredients Sales 2017-2022 (Kiloton)
Figure 40. Americas Sterile Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)
Figure 41. APAC Sterile Active Pharmaceutical Ingredients Sales 2017-2022 (Kiloton)
Figure 42. APAC Sterile Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)
Figure 43. Europe Sterile Active Pharmaceutical Ingredients Sales 2017-2022 (Kiloton)
Figure 44. Europe Sterile Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales 2017-2022 (Kiloton)
Figure 46. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)
Figure 47. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2021
Figure 48. Americas Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021
Figure 49. United States Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 50. Canada Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 51. Mexico Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 52. Brazil Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 53. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Region in 2021
Figure 54. APAC Sterile Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2021
Figure 55. China Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 56. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Korea Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 58. Southeast Asia Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 59. India Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 60. Australia Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 61. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2021
Figure 62. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021
Figure 63. Germany Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 64. France Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 65. UK Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 66. Italy Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 67. Russia Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 68. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2021
Figure 69. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021
Figure 70. Egypt Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 71. South Africa Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 72. Israel Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 73. Turkey Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 74. GCC Country Sterile Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Sterile Active Pharmaceutical Ingredients in 2021
Figure 76. Manufacturing Process Analysis of Sterile Active Pharmaceutical Ingredients
Figure 77. Industry Chain Structure of Sterile Active Pharmaceutical Ingredients
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...